Catalyst Wire Dossier Catalyst Wire Dossier

FURESTEM-CD Inj.

FURESTEM-CD · Kang Stem Biotech Co., Ltd.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FURESTEM-CD Inj., covering 2017-09-06 to 2018-03-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis [Phase 1]

See pricing